PEPTIDES AND PEPTIDE COMBINATIONS INTENDED FOR USE IN CANCER IMMUNOTHERAPY

MA51170AUndetermined Publication Date: 2020-10-21IMMATICS BIOTECHNOLOGIES GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA51170
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-04-10
Filing Date
2018-04-10
Publication Date
2020-10-21
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.